# Safety and Efficacy of Pulmonary Vein Isolation Using Pulsed-field Ablation (PFA) Combined with Either PFA-based Left Atrial Posterior Wall Isolation or Vein of Marshall Ethanol Ablation in Patients with Persistent Atrial Fibrillation

> **NCT06878924** · — · NOT_YET_RECRUITING · sponsor: **Texas Cardiac Arrhythmia Research Foundation** · enrollment: 162 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06878924
- **Lead sponsor:** Texas Cardiac Arrhythmia Research Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05
- **Primary completion:** 2027-05
- **Final completion:** 2027-12
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2025-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06878924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06878924, "Safety and Efficacy of Pulmonary Vein Isolation Using Pulsed-field Ablation (PFA) Combined with Either PFA-based Left Atrial Posterior Wall Isolation or Vein of Marshall Ethanol Ablation in Patients with Persistent Atrial Fibrillation". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06878924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*